GSK plc
Tracked across 37 events · 1546 articles · First seen Feb 10, 2025 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: GSK plc>>> is being acquired by GSK plc>>> for $10.6 billion, representing a 40% premium to its last closing price. This acquisition validates GSK plc>>>'s innovative work in developing targeted cancer therapies, particularly for lung cancer, and provides its shareholders with significant value.
Jun 09, 2026 · 56 articles
Tech
Impact: As a developer and funder of bepirovirsen, GSK plc stands to benefit significantly from the drug's potential approval and market success, enhancing its reputation and financial outlook in the pharmaceutical industry.
May 28, 2026 · 8 articles
Regulatory
Impact: GSK received FDA approval for its first lung cancer drug Jideytro, enhancing its oncology portfolio and potentially driving future revenue growth.
Jul 22, 2026 · 6 articles
Business
Impact: GSK is restructuring its R&D operations, closing Stevenage and opening a new Cambridge site, aiming to cut costs by £1.9 billion and reinvest in R&D. The move is strategically positive but involves short-term costs and job changes.
Jul 28, 2026 · 6 articles
Regulatory
Impact: GSK plc is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.
Dec 19, 2025 · 7 articles
Tech
Impact: GSK plc is the maker of the Zoster vaccine vaccine. The study, although funded by GSK plc, was independently designed and conducted, and its positive findings regarding dementia risk reduction could enhance the company's reputation and vaccine sales.
Jun 15, 2026 · 6 articles
Business
Impact: GSK plc is under investigation by Monteverde & Associates PC regarding its sale to GSK plc, with shareholders expected to receive $124.00 per share in cash.
May 19, 2026 · 45 articles
Business
Impact: GSK plc has adopted a more aggressive M&A approach following recent CEO transitions, contributing to the overall increase in dealmaking.
May 01, 2026 · 6 articles
Business
Impact: GSK holds exclusive license to Utebzi outside certain Asian territories; its sales payments back the financing.
Jul 14, 2026 · 9 articles
Regulatory
Impact: GSK plc benefits from the expanded label of the VENTANA MMR RxDx Panel as it identifies patients eligible for its Dostarlimab therapy, potentially increasing the drug's market reach.
Jun 11, 2026 · 6 articles
Business
Impact: Original developer supplying adjuvant; potential royalties if vaccine succeeds.
Jul 16, 2026 · 14 articles
Domestic
On August 10, 2026, President Donald Trump signed an executive order overhauling the U.S. childhood vaccine schedule. The order reduces the number of universally recommended vaccines from 18 to 11 diseases, recommends splitting the combined…
Impact: Another vaccine manufacturer, it also criticized the order and faces potential business implications if separate vaccines are developed.
Aug 10, 2026 · 235 articles
Tech
Impact: GSK plc>>>'s drug Avodart is mentioned in a comparison study where GLP-1s were associated with lower rates of prostate cancer diagnoses.
Jun 02, 2026 · 45 articles
Business
Impact: GSK plc had an executive, Jeremy Pincus, recognized with an Ignite Leadership Award for driving enterprise-wide AI transformations within the company.
Jun 25, 2026 · 8 articles
Tech
Cumulus Neuroscience announced the publication of final results from its CNS-102 study in Scientific Reports, demonstrating that its at-home NeuLogiq Platform is feasible, well tolerated, and highly usable for multimodal cognitive assessment in people living…
Impact: GSK is a consortium member. The publication may inform its clinical development programs in ALS and FTD.
Aug 18, 2026 · 6 articles
Domestic
Impact: GSK plc, a hepatitis B vaccine maker, defended its products as safe, and its shares finished 0.3% lower.
Dec 05, 2025 · 7 articles
Business
Impact: GSK plc>>> agreed to acquire GSK plc>>> for $10.6 billion, marking its largest deal in years and expanding its presence in cancer drug development.
May 20, 2026 · 72 articles
Regulatory
On August 5, 2026, the U.S. United States — Food and Drug Administration (FDA) approved Moderna's mFLUSIVA (mRNA-1010), the first mRNA-based seasonal influenza vaccine, for adults aged 50 and older. The approval covers traditional approval…
Impact: GSK plc's flu vaccines face potential competition from mFLUSIVA.
Aug 05, 2026 · 105 articles
Domestic
Impact: GSK plc, as the manufacturer of Wellcovorin (a branded version of leucovorin), was asked by the United States — Food and Drug Administration to file a new application with data on cerebral folate deficiency.
Sep 22, 2025 · 6 articles
Business
Impact: GSK plc is a partner of Innoviva, from whom Innoviva receives royalties on sales of respiratory assets.
Jun 01, 2026 · 6 articles
Business
Impact: GSK's RSV vaccine Arexvy faces increased competition from Moderna's mRESVIA in the EU market.
Jul 09, 2026 · 6 articles
Business
Impact: Soared 39% after GSK agreed to buy it for $10.6 billion.
Apr 20, 2026 · 344 articles
Business
Impact: GSK plc is AstraZeneca's main UK rival, which AstraZeneca overtook in size under Soriot. The merger would further widen the gap.
Aug 02, 2026 · 60 articles
Business
Impact: GSK plc's acquisition of Nuvalent Inc. is another example of big pharma M&A that supports biotech valuations.
Jul 06, 2026 · 25 articles
Business
Impact: GSK plc is mentioned as the former parent company from which Haleon was spun off in 2022, providing historical context to Haleon's current operations.
Jun 08, 2026 · 19 articles
Business
Dassault Systèmes — Medidata Solutions, a Dassault Systèmes brand and leading provider of clinical trial solutions, announced key appointments to its executive leadership team on August 10, 2026. Lisa Moneymaker, who joined the executive committee…
Impact: GSK plc is mentioned as a previous employer of Ian Marks, providing context for his experience but not directly affected by the event.
Aug 10, 2026 · 6 articles
International
The Strait of Hormuz, a critical waterway for global oil and LNG shipments, remains effectively closed following the US-Israel war on Iran that began on February 28. Iran has asserted control over the strait and…
Impact: Pharmaceutical company, whose stock fell on higher oil prices and inflation concerns.
Jul 28, 2026 · 318 articles
Business
Impact: GSK plc is mentioned as a customer of Syngene, but the event has no direct impact on the company.
Jul 01, 2026 · 6 articles
Business
Impact: Mentioned as part of 2026 M&A activity; acquired GSK plc for $10.6B.
Jul 06, 2026 · 34 articles
+ 7 more events
View on Dashboard
55
GSK plc stated supportTrump signs childhood...
50
GSK plc criticized vaccine splitting Donald TrumpTrump signs childhood...
+ 20 more relationships
View on Dashboard
ERGEN INTELLIGENCE
Track GSK plc live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard